[topsearch__bar__shortcode]

April 2022

CALA

Missed Q4 2021 Earnings Takes a Blow on Calithera Biosciences Inc. (CALA) After Hours

Leave a Comment / Featured, Morning News /

The oncology-focused clinical-stage biopharmaceutical company, Calithera Biosciences Inc. (CALA) has been trodden down since its IPO. Falling by over 83.84% last year, 2022 has been no different so far. The current year’s losses have extended to nearly 40% until now. Added to this the most recent events and happenings have only pushed the stock further […]

Missed Q4 2021 Earnings Takes a Blow on Calithera Biosciences Inc. (CALA) After Hours Read More »

DBGI stock

Digital Brands Group Inc. (DBGI) Down Post 2021 Financials Announcement

Leave a Comment / Featured, Morning News /

The apparel provider, Digital Brands Group Inc. (DBGI) posted its 2021 financial results on March 31, 2022. While the company’s latest earnings did show some nice YOY improvement, investors remained unimpressed. Thus, in the most recent trading session, DBGI sank by 5.26% to trade at $1.80 per share. Comparatively, the earlier trading session recorded a

Digital Brands Group Inc. (DBGI) Down Post 2021 Financials Announcement Read More »

LGVN Stock

Longeveron Inc. (LGVN)’s Alzhimer’s Study-Related Rally Culminate in Corrections

Leave a Comment / Featured, Morning News /

Aging brings multiple woes to the human body, including those ailments and disorders which impact the quality of life immensely. Some are even life-threatening. A company working on therapies for such conditions is Longeveron Inc. (LGVN). The clinical-stage biotech company garnered tremendous interest from investors on March 31, 2022. Thus, the stock was trending at

Longeveron Inc. (LGVN)’s Alzhimer’s Study-Related Rally Culminate in Corrections Read More »

Stocks
Telegraph

At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.

About

Categories

Social Links

Facebook Twitter Youtube Instagram Linkedin